Jake Pours A Special Treat for the Bears
_______________________________________
You can tell by the twinkle in his eye that old Pat Boone’s having a special day. And so are tthe loyal Jacksonian JakeGint Brigade.
Gold is now in new all-time high territory @ $1041.70 an ounce, having smashed the former $1,033 ceiling with gusto this morning, as our friend, Mr. Dollar plummets once again to it’s flash-paper grave.
In the meantime, silver is the purchase of the century as it still lags gold in targetting and achieving it’s old $20+ highs. Silver is still one-sixtieth the price of gold as well, compared to more historic ratioss of 40:1.
I’m still targetting a $21.95 price for [[UUP]] , and we may break to new lows from there, thanks to swarthy men wearing bedsheets and mis-treating their camels half-way across the world.
How dare they object to our running off sheets and sheets of green paper with Ben Franklin’s visage on it and exchanging said specie for their greasy petrol? Don’t they know what attractive wall covering that shade of grey-green can provide?
Not to mention window-treatments.
Not to get all “stuffed-in-the-gut” about how all my dollar defense dragons are tearing ass on this market and making investments in TV-tubes and natty gas service companies look like so much Baltic Avenue rowhouse property (we have Mr. Boone for that purpose anyway), I’d like to point out some exaggerated gorillas whose armpits you may wish to shave at some point today…
(That means “take some fiat off the table” for the metaphorically challenged)
Silver Wheaton Corp. (USA) [[SLW]] will likely come back to it’s breakout at $13.35 or so.
Hecla Mining Company [[HL]] is a crazy stock and will likely meet stiff resistance at $5.00.
Wait for a break of $21.96 to get back on [[CDE]] , otherwise, it should fill that gap again at $20.41
Silver Standard Resources Inc. (USA) [[SSRI]] has an optimal entry at $21.75, but otherwise it should get held up at $23.25 or so for the near term.
[[PAAS]] is “BTFO,” but will likely return to it’s old high of $24.81 before heading to new pastures.
Golden Star Resources Ltd. (USA) [[GSS]] will be BTFO at $3.71, but is a buy on a pullback to $3.38.
That’s enough free fritatas for now, pikers. Sign up for The PPT to get the full-fire hose effect of instant portfolio nutrition.
Off to commiserate with mountain dwarves and other horders of glittering treasure piles.
Slante.
_________________
If you enjoy the content at iBankCoin, please follow us on Twitter
CDE appears to be experiencing a minor pullback here… probably a purchase at $21.44 if you can grab it at rest.
_________
Jake,
I’m finally banking some coin!!! It looks like my PMPIX will be up at least another 6% to 7% today after its4.98% yesterday.
You can quickly look at ABX and the gap up to get an idea of what this fund is doing.
So I’m thinking get out at the end of the day and watch it for awhile or at least lighten up.
Your thoughts good sir?
Thanks
I would pare it back at least 50%, but you should keep some of it for the long term hold… maybe with a stop if you insist on taking profits at every turn.
I’m not a big fan of paying taxes for intermediate term moves.
_______
Thanks Jake,
You can’t use stops with Profunds. I wish you could.
You have to either get out, lighten up, or ride it out.
Thanks for advice, I will lighten up.
40:1? I had always heard the historic ratio was 12:1.
Well, it depends upon what you mean by “historical.”
I’m talking “near term” history… since Bretton Woods history.
19th century silver:gold was fixed in a lot of countries (including this one) at 16:1.
I’m not familiar w. 12:1, though.
___________
I was probably thinking of the 16:1 ratio.
Possible (daily) shooting star candlestick on some of these sliver miners now. (SSRI, SWC, SLW)
You mean like on 6/24 or 7/14 of this past summer?
😉
________
Things are looking better on the candlestick now…I spoke too soon! I’ve got AU, AUY, GG, GOLD, SLW, SSRI and SWC from last week’s over sold signal on the RSI (7).
That’s a lineup I’d take for anyone’s fantasy football league.
You’re light on silver though. Don’t forget PAAS, EXK, CDE and even that shit-bird HL.
Silver will outperform all.
_____________
Also BAA looks very tasty here, finishing strong.
_________
Thanks, I know Gary S likes the silver plays too…I will add some of those. What % of your portfolio is in the pm’s? I’m guessing you buy and hold in your iras, 401ks and trade short term on these guys too?
I scanned Gary Savage’s junior miner list (there’s like 50 or so of them) and just have not been able to bring myself to buy any of them. There might have been a few in there, but a bunch of penny stocks. I heard Market Vectors was putting together an ETF of the juniors…Don’t know where they are at on that fund now.
BAA is one of Gary’s… moving and grooving.
I’m over 70 % metals and PM’s now.
Released this a bit ago on the PPT, so here it is now for public —
“UUP hit it’s short-term downtrend line that initiated on 10/2 and ran through 10/5 to be touched again today @ 22.68. I expect the dollar to turn lower again from here.”
UUP currently @ 22.65.
_________
You the man Jake, that is all.
CDE cranking back up… that drop to $21 was a gift….
_______
Daily MACD on most of these have all curled up. Hopefully a powerful move is in the works now.
incredible call.
“Persistent” and/or “stubborn” may be the better descriptives, but thanks for the compliment anyways.
I’ve still got a lot of Fly picks stashed as well, including GLW, indeud!
_____
Dumped my shorter term CDE calls (October 17.5 strikes) @ $4.20 for a 55%+ return over a couple of weeks.
Still have the Decembers in CDE, GDX and SSRI.
__________
Hmmmm….for now that 76 and change number on the dollar held up again. Bounced off it and didn’t break through today. The trend is down regardless, but we are squeezing into a tight little triangle with the down sloping trend line giving resistance from above. Something’s got to give. I think we break under 76 now and test the 74 area.
http://tiny.cc/d3ggD
That’s the second time your tiny cc “hasn’t loaded” — you might want to try bitly or post the original URL.
___________
That’s strange…Works when I click it from my end. Really nothing special about the chart either. Try again with the original.
http://www.screencast.com/users/Jayhawk1991/folders/Jing/media/03f1ddfd-af91-4919-bc39-842f44ff492e
Hi Jake,
Now that we’re back in our desert abode (briefly), and back on the e-mail I originally signed on to ibc with, let me see if I can comment without being “moderated” fordamnever.
First, congrats on the blog, on your calls, and on banking mega coin. Even though I’ve been unable to post here since last May, I’ve been able to follow almost daily what goes on here.
Second, I think I heard on cnbc today some one say that gold would have to close over $2300.00, inflation adjusted to break its’ all time high. Does this sound right?
Brushbuck —
Welcome back, glad you could get on… if you get “moderated” it’s usually a mistake… just alert me or send an email to Jeremy and I can fish your comment out.
And yes, I think that it’s right around $2,400 inflation adjusted, if I recall correctly.
Of course, “new high” mania does not take “inflation adjusted” numbers into it’s analysis. The $1,033 was an important hurdle.
_____
Excellent work Jake… Not that I need to point that out.
Thanks Bubbles… you were awesome in The Wire.
Hope you’ve got all 12 Steps down and done.
______
Yaaay! I’m back in comment mode business. Not that I do all that much…but every once in a while I’d like to ask a question or some such.
Well then, if we’re talking even remotely about gold and/or silver even appraching their inflation adjusted highs…we could be in for one heck of a run.
Thanks, Jake, and continued good luck.
Jake – Great job on the PM’s.
Thks, Y&BB!
_
All over that silver in the AM Jake…thank you !!
As long as I don’t have to “down and give you twenty” I’m relieved to be of service.
______-
Long post warning. By command of Captain Gint; prelimary review of HEB (has a product out there) and CVM. Regrets in advance should my review turn negative for holders.
Management passes [my] initial muster at HEB, I’m not there with CVM yet. Look at HLCS to see what makes me feel warm and fuzzy from the git go, and one of the factors in my decision to load up with abandon well under $2 and keep buying on the dips. I will of course drown under the curse of HLCS one day, but hopefully not before I get to bank some more coin well north of here this month.
HLCS
Mr. Ronald Lowy Chief Executive Officer
Mr. Lowy joined the Helicos Board of Directors in November 2007 and was appointment CEO in December 2008. He has more than 30 years of experience managing and growing technology based global businesses.
As president and CEO of Fisher Biosciences, a division of Fisher Scientific, Mr. Lowy was responsible for 14 business units with more than 5,000 employees in 56 locations in 100 countries around the world. Before joining Fisher Biosciences, Mr. Lowy was president of Global Connectivity Solutions for ADC Telecommunications. He also served as president and Chief Operating Officer at the KRONE Group where he was responsible for all facets of this global business unit. Mr. Lowy spent the first 15 years of his career in operations, technology and general management positions at GE Medical Systems where he was intimately involved with the development and commercialization of Computerized Tomography and Magnetic Resonance Systems.
Mr. Lowy earned his Master of Business Administration from the University of Wisconsin and a bachelor’s of science degree in mechanical engineering from the University of New Hampshire.
Mr. Steve Lombardi President
Mr. Lombardi joined Helicos in June 2006. He has over 27 years of commercial biotechnology experience, as a researcher and in various business management and executive positions. Prior to joining Helicos, he was Senior Vice President at Affymetrix, serving in executive positions in Corporate Development, Product Development and Research and Corporate Marketing. Before Affymetrix, Mr. Lombardi worked for 16 years at Applied Biosystems in various business roles, first as a marketing manager and later as a senior executive.
From 1989 to 1998, Mr. Lombardi led the formation of the company’s DNA sequencing and genetic analysis business, the products of which formed the technological basis of the worldwide Human Genome Project. He was also involved in the formation of Celera within the broader Applera corporate structure. Prior to joining Applied Biosystems, Mr. Lombardi spent 8+ years as a nucleic acids chemist focused on the development of novel approaches to DNA synthesis. He earned his BA in Biology from Merrimack College.
HEB
Dr. Carter, the co-inventor of Ampligen®, joined the Company in 1978, and has served as the Company’s Chief Scientific Officer since May 1989, the Chairman of the Company’s Board of Directors since January 1992, the Company’s Chief Executive Officer since July 1993, the Company’s President since April, 1995, and a director since 1987. From 1987 to 1988, Dr. Carter served as the Company’s Chairman. Dr. Carter was a leading innovator in the development of human interferon for a variety of treatment indications including various viral diseases and cancer. In this context, he received the first FDA approval to initiate clinical trials on a beta interferon product manufactured in the U.S. under his supervision. From 1985 to October 1988, Dr. Carter served as the Company’s Chief Executive Officer and Chief Scientist. He received his M.D. degree from Duke University and underwent his post-doctoral training at the National Institutes of Health and Johns Hopkins University. Dr. Carter also served as Professor of Neoplastic Diseases at Hahneman Medical University, a position he held from 1980 to 1998. He also served as Director of Clinical Research for Hahneman Medical University’s Institute for Cancer and Blood Diseases, and as a professor at Johns Hopkins School of Medicine and the State University of New York at Buffalo. He is a Board certified physician and author of more than 200 scientific articles, including the editing of various textbooks on anti-viral and immune therapy.
CVM
President
Mr. de Clara founded CEL-SCI Corporation in March 1983 and has been a Director of CEL-SCI since its inception and has been President of CEL-SCI since July 1983. Prior to his affiliation with CEL-SCI, Mr. de Clara was involved in the management of his personal investments and personally funded research in the fields of biotechnology and biomedicine.
Mr. de Clara attended the medical school of the University of Munich from 1949 to 1955. During the summers of 1954 and 1955, he worked as a research assistant at the University of Istanbul in the field of cancer research. For his efforts and dedication to research and development in the fight against cancer and AIDS, Mr. de Clara was awarded the “Pour le Merit” honorary medal of the Austrian Military Order “Merito Navale.” He was awarded the honor cross of the Austrian Albert Schweitzer Society.
CEO
Geert Kersten has served in his current leadership role at CEL-SCI since 1995. Mr. Kersten has been with CEL-SCI from the early days of its inception since 1987. He has been involved in the pioneering field of cancer immunotherapy for almost two decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry.
Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how the company’s Multikine® product will change the way cancer is treated. Prior to CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital, an investment banking firm located in McLean, VA.
He is a native of Germany, graduated from Millfield School in England, and completed his studies in the US. Mr. Kersten completed his Undergraduate Degree in Accounting, received an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC.
Thanks Doc. Any opinion on their various product suites?
____
Working on it, but will take another day or so. I’m pretty familiar with the HEB interferon since I’m an OB/Gyn. Not terribly popular for a number of good reasons, however the interferon concept seemed to have a lot of legs at one point. I’ll be getting refreshed on the subject.
“Mr. de Clara attended the medical school of the University of Munich from 1949 to 1955” didn’t see much else about the next 30 years. I hate gaps of 30 years…
Thanks Doc. Posts like this is what make iBC. (geeez do I sound like a shill or what?)
BTW Thoughts on ILI? I had it added over in the PPT.
Zee Germanz cannot be trusted
New post pointing out the opportunity in silver — In Smaug’s Lair.
Running w. that Tolkien theme tonight…
___________
“chitinous carapace” – now that’s a phrase I have to try out tomorrow. I bid you good night Mr. Gint.
I like the “almost alliteration” of it.
Truthfully, I was just checking the spelling on “carapace” and I saw “chitinous” used in the sentence illustrating the word in the online dictionary and I said — “no way I’m leaving that word behind.”
Used w. “chitinous” carapace really means “exoskeleton” as in an insect or sea-going arthropod.
________
CVM – Maximilan De Clara is a freakin ghost, where the hell was he for 25 years. Name sounds like lots of old money, the kind that you can’t talk about. Strange…but what the heck. Movin’ on.
I get the multikine story, and the good phase ll report, but the meat is in phase lll – that takes a partner for them, and is a toss of the dice. Their other line is just getting some PR related to the flu thingy but seems pretty weak to me. Definitely not a mainstream kinda biotech. Kinda cultish waldorfian if you know what I mean. I feel a need to felt something or put on a play.
Seems pretty speculative, they’ve been pushing this stuff for a very long time. I might buy some for my sampler collection at around a buck. That’s my best offer tonight.
A deep read;
http://msnmoney.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingORIG1?ID=6344901&SessionID=XkeCWxRwJUf11m9
By the way, de Clara didn’t finish medical school. 6 years – what the hell was he doing?